BriaCell Therapeutics Corp. (BCTX) stock
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
$3.51−0.08 (-2.23%)
Close on Nov 12, 2026Market cap $30.65MP/E –Yield –
BriaCell Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BriaCell Therapeutics's enterprise value was $9.88M on Nov 11, 2026, against -$7.84M a year earlier. Over the last 5 years it ranged from -$25.21M to $93.83M, with a median of $16.80M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.88M | – |
| 2025 | Nov 28, 2025 | -$82.67K | -100.6% |
| 2024 | Dec 31, 2024 | $14.32M | -82.0% |
| 2023 | Dec 29, 2023 | $79.64M | +159.1% |
| 2022 | Dec 30, 2022 | $30.74M | -56.0% |
| 2021 | Dec 31, 2021 | $69.87M | +2250.9% |
| 2020 | Dec 31, 2020 | $2.97M | – |
See a number that looks wrong?